Company intelligence / Profile preview

Chia Tai Pharmaceutical

Lianyungang, Jiangsu, Chinatrackmyswift.com ↗

Ownership: Private
Employees: ~14000
Development stage: Other

Overview

CTTQ has over fifty prescription medicines on the market across five core therapeutic areas. It has a robust pipeline of more than one hundred ninety projects—over forty percent are innovative drug projects. Several biosimilars and generics have been approved in China and abroad. Notable launches include bevacizumab biosimilar for non-small cell lung cancer and magnesium isoglycyrrhizinate hydrate for liver disease. Clinical trials span small molecules to monoclonal antibodies; some assets have reached US/EU markets.

Therapeutic areas: PulmonologyInfectious DiseasesGastroenterologyEndocrinologyOncologyMen's Health
Modalities: Small moleculeMonoclonal antibodyBiosimilarBiological productsChemical drugs
Industry: Pharma

Partnerships

Techdow USA Inc. – licensing/supply/distribution agreement for Fosaprepitant for Injection in US market

Beyond the preview

Go deeper on Chia Tai Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chia Tai Pharmaceutical.

Explore the full profile